Hypertension Pulmonary Clinical Trials

ReadTheTrial indexes 2 studies for Hypertension Pulmonary. The most common development stage is Phase 2 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

2 clinical trials found for Hypertension Pulmonary.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 1
50%
Phase 3 1
50%

Trial Status Breakdown

Trials for Hypertension Pulmonary

A Phase 2, Multicenter, Double-blind, Extension Study to Evaluate the Effects of Sotatercept for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension (Cpc-PH) Due to Heart Failure With Preserved Ejection Fraction (HFpEF)

NCT06814145 · RECRUITING · Phase 2

Open-label, Individual Dose Titration Study to Evaluate Safety, Tolerability and Pharmacokinetics of Riociguat in Children From 6 to Less Than 18 Years of Age With Pulmonary Arterial Hypertension (PAH)

NCT02562235 · ACTIVE NOT RECRUITING · Phase 3

Frequently Asked Questions

What clinical trials are available for Hypertension Pulmonary?

There are 2 clinical trials listed for Hypertension Pulmonary. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Hypertension Pulmonary trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Hypertension Pulmonary trials in?

Current Hypertension Pulmonary trials are distributed across: Phase 2 (1), Phase 3 (1).

Find More Trials